(RELX) Relx - Ratings and Ratios
Information, Analytics, Decision Tools, Data Sets, Business Information
Description: RELX Relx
RELX PLC is a global provider of information-based analytics and decision tools, serving professional and business customers across North America, Europe, and internationally through four distinct segments: Risk, Scientific, Technical & Medical, Legal, and Exhibitions. The companys diverse offerings cater to various industries, including risk management, scientific research, legal services, and trade exhibitions.
From a business perspective, RELX PLCs segments demonstrate a strong presence in their respective markets. The Risk segment leverages data analytics to help clients assess and mitigate risk, while the Scientific, Technical & Medical segment provides critical information to researchers and healthcare professionals. The Legal segment offers valuable insights and analytics to legal professionals, and the Exhibitions segment facilitates face-to-face interactions and digital engagement for businesses. With a rich history dating back to 1903 and a global footprint, RELX PLC has established itself as a leader in its field.
To further evaluate RELX PLCs performance, we can examine key performance indicators (KPIs) such as revenue growth, operating margins, and dividend yield. RELX PLC has consistently demonstrated strong revenue growth, driven by a combination of organic growth and strategic acquisitions. The companys operating margins are also impressive, reflecting its ability to efficiently manage operations and invest in high-growth areas. Additionally, RELX PLCs dividend yield is attractive, indicating a commitment to returning value to shareholders. Other relevant KPIs include the companys debt-to-equity ratio, return on assets (ROA), and earnings per share (EPS) growth.
From a valuation perspective, RELX PLCs price-to-earnings (P/E) ratio of 37.98 and forward P/E of 30.03 suggest that the stock may be slightly overvalued relative to its earnings growth prospects. However, the companys strong track record of profitability, as reflected in its return on equity (RoE) of 110.69, supports its premium valuation. To gain a more comprehensive understanding of RELX PLCs valuation, we can also consider metrics such as the price-to-book (P/B) ratio, enterprise value-to-EBITDA (EV/EBITDA), and dividend payout ratio.
RELX Stock Overview
| Market Cap in USD | 89,368m |
| Sub-Industry | Research & Consulting Services |
| IPO / Inception | 1994-10-07 |
RELX Stock Ratings
| Growth Rating | 75.9% |
| Fundamental | 83.3% |
| Dividend Rating | 46.6% |
| Return 12m vs S&P 500 | -12.7% |
| Analyst Rating | 4.0 of 5 |
RELX Dividends
| Dividend Yield 12m | 1.71% |
| Yield on Cost 5y | 4.01% |
| Annual Growth 5y | 5.19% |
| Payout Consistency | 92.4% |
| Payout Ratio | 79.0% |
RELX Growth Ratios
| Growth Correlation 3m | -79.5% |
| Growth Correlation 12m | 72.2% |
| Growth Correlation 5y | 93.8% |
| CAGR 5y | 18.15% |
| CAGR/Max DD 5y | 0.69 |
| Sharpe Ratio 12m | 0.14 |
| Alpha | -8.43 |
| Beta | 0.559 |
| Volatility | 17.76% |
| Current Volume | 2261.7k |
| Average Volume 20d | 1394.9k |
| Stop Loss | 45.5 (-3.1%) |
| Signal | -2.81 |
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (3.82b TTM) > 0 and > 6% of Revenue (6% = 1.13b TTM) |
| FCFTA 0.35 (>2.0%) and ΔFCFTA 9.14pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -16.14% (prev -39.34%; Δ 23.20pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.37 (>3.0%) and CFO 5.31b > Net Income 3.82b (YES >=105%, WARN >=100%) |
| Net Debt (7.32b) to EBITDA (4.40b) ratio: 1.67 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.47 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.84b) change vs 12m ago -3.46% (target <= -2.0% for YES) |
| Gross Margin 64.67% (prev 61.09%; Δ 3.58pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 146.4% (prev 114.4%; Δ 32.01pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.81 (EBITDA TTM 4.40b / Interest Expense TTM 533.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.41
| (A) -0.21 = (Total Current Assets 2.73b - Total Current Liabilities 5.77b) / Total Assets 14.32b |
| (B) 0.13 = Retained Earnings (Balance) 1.89b / Total Assets 14.32b |
| (C) 0.32 = EBIT TTM 4.16b / Avg Total Assets 12.87b |
| (D) 0.18 = Book Value of Equity 2.22b / Total Liabilities 12.13b |
| Total Rating: 1.41 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 83.30
| 1. Piotroski 8.0pt = 3.0 |
| 2. FCF Yield 6.77% = 3.38 |
| 3. FCF Margin 26.69% = 6.67 |
| 4. Debt/Equity 3.81 = -1.83 |
| 5. Debt/Ebitda 1.89 = 0.22 |
| 6. ROIC - WACC 24.49% = 12.50 |
| 7. RoE 123.8% = 2.50 |
| 8. Rev. Trend 94.94% = 4.75 |
| 9. Rev. CAGR 12.92% = 1.62 |
| 10. EPS Trend 19.80% = 0.50 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of RELX shares?
Over the past week, the price has changed by -2.55%, over one month by -8.80%, over three months by -14.24% and over the past year by +2.77%.
Is Relx a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RELX is around 47.04 USD . This means that RELX is currently overvalued and has a potential downside of 0.17%.
Is RELX a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the RELX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 56.5 | 20.2% |
| Analysts Target Price | 56.5 | 20.2% |
| ValueRay Target Price | 51.9 | 10.6% |
Last update: 2025-08-22 04:47
RELX Fundamental Data Overview
CCE Cash And Equivalents = 211.0m GBP (Cash And Short Term Investments, last quarter)
P/E Trailing = 34.7786
P/E Forward = 27.8552
P/S = 9.3359
P/B = 30.2755
P/EG = 2.6552
Beta = 0.475
Revenue TTM = 18.84b GBP
EBIT TTM = 4.16b GBP
EBITDA TTM = 4.40b GBP
Long Term Debt = 6.36b GBP (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 1.94b GBP (from shortTermDebt, last quarter)
Debt = 8.30b GBP (Calculated: Short Term 1.94b + Long Term 6.36b)
Net Debt = 7.32b GBP (from netDebt column, last quarter)
Enterprise Value = 74.28b GBP (66.19b + Debt 8.30b - CCE 211.0m)
Interest Coverage Ratio = 7.81 (Ebit TTM 4.16b / Interest Expense TTM 533.0m)
FCF Yield = 6.77% (FCF TTM 5.03b / Enterprise Value 74.28b)
FCF Margin = 26.69% (FCF TTM 5.03b / Revenue TTM 18.84b)
Net Margin = 20.26% (Net Income TTM 3.82b / Revenue TTM 18.84b)
Gross Margin = 64.67% ((Revenue TTM 18.84b - Cost of Revenue TTM 6.66b) / Revenue TTM)
Tobins Q-Ratio = 33.49 (Enterprise Value 74.28b / Book Value Of Equity 2.22b)
Interest Expense / Debt = 2.64% (Interest Expense 219.0m / Debt 8.30b)
Taxrate = 23.97% (from yearly Income Tax Expense: 613.0m / 2.56b)
NOPAT = 3.17b (EBIT 4.16b * (1 - 23.97%))
Current Ratio = 0.47 (Total Current Assets 2.73b / Total Current Liabilities 5.77b)
Debt / Equity = 3.81 (Debt 8.30b / last Quarter total Stockholder Equity 2.18b)
Debt / EBITDA = 1.89 (Net Debt 7.32b / EBITDA 4.40b)
Debt / FCF = 1.65 (Debt 8.30b / FCF TTM 5.03b)
Total Stockholder Equity = 3.08b (last 4 quarters mean)
RoA = 26.65% (Net Income 3.82b, Total Assets 14.32b )
RoE = 123.8% (Net Income TTM 3.82b / Total Stockholder Equity 3.08b)
RoCE = 44.11% (Ebit 4.16b / (Equity 3.08b + L.T.Debt 6.36b))
RoIC = 31.89% (NOPAT 3.17b / Invested Capital 9.93b)
WACC = 7.39% (E(66.19b)/V(74.49b) * Re(8.07%)) + (D(8.30b)/V(74.49b) * Rd(2.64%) * (1-Tc(0.24)))
Shares Correlation 5-Years: -97.50 | Cagr: -1.13%
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 81.36% ; FCFE base≈4.20b ; Y1≈5.18b ; Y5≈8.84b
Fair Price DCF = 81.93 (DCF Value 149.78b / Shares Outstanding 1.83b; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 94.94 | Revenue CAGR: 12.92%
Rev Growth-of-Growth: -13.48
EPS Correlation: 19.80 | EPS CAGR: 0.0%
EPS Growth-of-Growth: -5.61
Additional Sources for RELX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle